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Maturation of a vascular plexus is a critical and yet
incompletely understood process in organ develop-
ment, and known maturation factors act universally
in all vascular beds. In this study, we show that
CXCL12 is an organ-specific maturation factor of
particular relevance in coronary arterial vasculature.
In vitro, CXCL12 does not influence nascent vessel
formation, but promotes higher-order complexity of
preinitiated vessels. In the heart, CXCL12 is ex-
pressed principally by the epicardium, and its recep-
tor CXCR4 is expressed by coronary endothelial
cells. CXCL12 is not a chemotactic signal for endo-
thelial cell migration, but rather acts in a paracrine
manner to influence the maturation of the coronary
vascular plexus. Mutants in CXCL12 signaling show
an excess of immature capillary chains and a selec-
tive failure in arterial maturation, and become leaky
with the onset of coronary perfusion. Failed matura-
tion of the coronary system explains the late-gesta-
tion lethality of these mutants.
INTRODUCTION
Formation of the vascular system is tightly regulated by the spatial
and temporal expression of various factors (Jain, 2003). Vascular
endothelial growth factor (VEGF) promotes the assembly of endo-
thelial progenitors into a nascent immature plexus (Ferrara et al.,
1996;Carmeliet et al., 1996) and also promotes specification to an
arterial fate (Hong et al., 2006; Lawson et al., 2002; Mukouyama
et al., 2005). The newly formed plexus then undergoes a complex
and incompletely understood process of vascular maturation
that involves pruning and reorganization into a hierarchical
network of larger and smaller arteries and veins; for arteries,
plexus maturation also involves assembly of a surrounding layer
of smooth muscle. Connection to systemic circulation initiates
perfusion and additional remodeling processes that continue
through life. Several signaling pathways have been implicated in
plexusmaturation, including angiopoietin (Suri et al., 1998), ephrinDeve(Wang et al., 1998), andNotch (Duarte et al., 2004), although these
appear to be universally required in all vascular compartments.
In contrast, there is also evidence for organ-specific maturation
processes that are thought to be controlled by unique locally
expressed molecules (Jain, 2003; Wang et al., 2012), although
few if any such factors have been identified.
In mouse heart development, cells from the proepicardium
migrate onto andadhere to theoutermyocardial surfacebetween
embryonic days E9.5 and E10.5, forming the epicardium (Seng-
busch et al., 2002). Coronary endothelial cells first assemble
into aplexus in the spacebetween the epicardiumandventricular
myocardium, then associate with epicardium-derived smooth
muscle cells as thenascent tubes coalesce andbecome incorpo-
rated into the ventricular wall (Red-Horse et al., 2010). Coronary
veins remain close to the outer surface, whereas coronary ar-
teries become more deeply positioned. Ingrowth of the anterior
endsof the arteries into the ascending aorta at E14 initiates perfu-
sion and coronary circulation (Chen et al., 2014; Tian et al.,
2013a). The molecular signals that promote differentiation of
theprimitive plexus to assemble themature coronary vasculature
of the embryonic ventricular wall are largely unknown.
The chemokine CXCL12, also known as SDF1, has chemo-
tactic and mitogenic activity on many cell types (Nagasawa,
2014). Various nonexclusive roles for CXCL12 signaling in vascu-
logenesis have been proposed, including endothelial cell migra-
tion (Siekmann et al., 2009), arterial-nerve alignment (Li et al.,
2013), and mediation of plexus connections to systemic arteries
(Ara et al., 2005). CXCL12 primarily acts through the G protein
coupled receptor CXCR4; global mouse knockouts of Cxcl12
or of Cxcr4 die shortly before birth with vascular deficiencies in
the gut, kidney, and skin, and with a number of additional he-
matopoietic and neural defects (Ma et al., 1998; Nagasawa
et al., 1996; Tachibana et al., 1998; Zou et al., 1998). Endothe-
lium-specific Tie2Cre/Cxcr4 mutants replicate the vascular
phenotype of global mutants (Ara et al., 2005; Takabatake
et al., 2009). Except for an unexplained ventricular septal defect,
cardiac development was not closely examined. Importantly, the
known defects cannot explain the late-gestation lethality seen in
the global or conditional mutants.
In the present study, we found that CXCL12 has potent activity
in vascular plexusmaturation, although not in the initial assembly
of the vascular plexus. We demonstrate that this function is
particularly relevant in the maturation of the coronary arteriallopmental Cell 33, 469–477, May 26, 2015 ª2015 Elsevier Inc. 469
Figure 1. CXCL12 Promotes PlexusMatura-
tion In Vitro
(A–L) Representative images of HUVEC-covered
beads in fibrin gels after 3, 5, and 7 days of culture.
Note the absence of sprouting in control condi-
tions (A, E, I) or with CXCL12 alone (B, F, J). VEGF
induced sprouting at 3 days (C) and the formation
of tubes at 5 and 7 days (G, K). Treatment with
VEGF plus CXCL12 (D, H, L) increased the
complexity of the endothelial network by days 5
and 7. The negative control was endothelial basal
media (EBM-2) plus 2% FBS with no added
growth factors; VEGF and CXCL12 were added at
20 ng/ml and 100 ng/ml, respectively.
(M) Quantitation of total number of sprouts, tubes,
branching points, and anastomosis in the fibrin
bead assay. The data are normalized to the num-
ber of beads present in each microscopic field.
Data are represented as mean ± SEM. *p < 0.001
versus VEGF alone.
See also Figure S1.vasculature. Absence of CXCL12/CXCR4 signaling results in a
poorly formed coronary system and insufficient myocardial
perfusion, and accounts for late-gestation lethality seen in these
mutants.
RESULTS
CXCL12 Promotes Higher-Order Vascular Plexus
Organization In Vitro
Many aspects of early vascular plexus formation and maturation
are modeled by the behavior of HUVEC endothelial cells in fibrin
gels (Nakatsu et al., 2003), including the formation of vascular
sprouts, lumenized tubes, branches, and anastomoses of470 Developmental Cell 33, 469–477, May 26, 2015 ª2015 Elsevier Inc.branches with other tubes (Figures S1A–
S1E). Using this assay, we measured
initial endothelial cell sprouting at 3 days
and the complexity of lumenized tubes at
5 days to test the role of CXCL12 and its
possible interaction with VEGF. In the
absence of added factors (Figures 1A,
1E, and 1I) or with CXCL12 alone (Figures
1B, 1F, and 1J), no outgrowth occurred
even as late as 7 days after plating.
VEGF induced sprouting at 3 days (Fig-
ure 1C) and formation of tubes at 5 days
(Figure 1G), as previously reported (Na-
katsu et al., 2003). Addition of the
CXCR4 antagonist AMD3100 to VEGF-
treatedcultureshadnoeffect (FigureS1F),
indicating that CXCL12 is not made by
endogenous components of this assay
and that CXCR4 is not required for the
VEGF response. The number of primary
sprouts that originated from each bead
was unchanged when CXCL12 was
added with VEGF (Figures 1D and 1M).
CXCL12 also did not influence VEGF-
induced changes in HUVEC arterial orvenous gene expression (Figure S1I). However, the combination
of CXCL12 with VEGF dramatically increased the complexity of
the endothelial tube network by day 5, as manifest both by the
number of tubes (i.e., primary tubes plus branched tubes) and
by the number of anastomoses between tubes (Figures 1H and
1M). Thus, in vitro, CXCL12 does not initiate vasculogenesis or
alter arterial-venous specification but rather promotes further re-
modelingof aplexus that is initially inducedbyVEGF (FigureS1H).
CXCL12 Expression during the Period of Mouse
Coronary Vessel Formation
The majority of coronary endothelial cells of the embryonic
ventricular wall are thought to originate from the sinus venosus
Figure 2. CXCL12 and CXCR4 Expression during Coronary Vessel Development
(A–F) In situ hybridization with antisense probe for Cxcl12 shows expression in the epicardium in wild-type embryos. (A) Cxcl12 is expressed in the epicardium
surrounding the atrioventricular canal at E10.5. (B) Hybridization with a sense control. (A0) and (B0 ) are magnified views of the boxed region in (A) and (B). (C–F)
Cxcl12 is expressed in the epicardium at E11.5 (C), E12.5 (D), E14.5 (E), and in both epicardium and epicardium-derived smooth muscle surrounding coronary
blood vessels (arrowheads) at E16.5 (F).
(G–I) CXCR4 is expressed in endothelial cells sprouting from the sinus venosus at E11.5 (arrowheads). The dotted lines outline the pericardial cavity. CD31
(Pecam1), a pan-endothelial marker (green, G), CXCR4 (red, H), and merged channels (I) are shown.
Abbreviations: oft, outflow tract; ra, right atria; rv, right ventricle; avc, atrioventricular canal; sv, sinus venosus; li, liver; epi, epicardium. See also
Figure S2.and migrate between the epicardium and myocardium (Red-
Horse et al., 2010; see also below). In mice, this process initi-
ates at embryonic day E11.5 on the dorsal side of the heart at
the atrioventricular canal, with expansion and maturation of
the plexus occurring over the next several days. Cxcl12 was
expressed throughout the E10.5–E16.5 interval in the epicar-
dium (Figures 2A–2F); this included the epicardium of the
atrioventricular canal and over the ventricle. Cxcl12 may also
be expressed at a uniform low level in the myocardium; we
measured 4-fold lower expression in isolated primary embry-
onic ventricular cardiomyocytes compared with primary ven-
tricular epicardial cells (Figure S2A). Cxcl12 expression was
also detected in the wall of the aorta during this period (Fig-
ure S2B), by cells of presumptive neural crest origin (Choudh-
ary et al., 2009). Consistent with epicardial expression in vivo,DeveCXCL12 is secreted at an abundant level by immortalized
MEC1 mouse embryonic ventricular epicardial cells (Fig-
ure S2C). In MEC1 and in primary mouse embryonic epicardial
cells, the Cxcl12 gene was induced by hypoxia (Figure S2D),
as observed in other cell types (Santiago et al., 2011; Sun
et al., 2010). Cxcl12 was expressed later by epicardium-
derived smooth muscle cells surrounding mature coronary
blood vessels (Figure 2F). The receptor Cxcr4 was expressed
at E11.5 in sinus venosus endothelium, in endothelial cells
sprouting from the sinus venosus toward the ventricle, and
in heart endocardium (Figures 2G–2I; Figures S2E–S2G), a
pattern identical to the venous marker endomucin (Emcn) (Fig-
ures S2H–S2N). Thus, the spatial and temporal expression of
Cxcl12 and Cxcr4 are consistent with a role in coronary
vascular development.lopmental Cell 33, 469–477, May 26, 2015 ª2015 Elsevier Inc. 471
Figure 3. Defective Coronary Vessel Organization in Embryos with Disrupted CXCL12 Signaling
(A–H) Whole-mount CD31 immunostaining of hearts (dorsal surfaces) from control (A–D) and conditional Tie2Cre/Cxcr4 mutants (E–H) at the indicated stages.
Dotted lines indicate the extent of endothelial cell plexus organization within the ventricle. The diffuse staining at E11.5 on the ventricular surface corresponds to
CD31-positive endocardium (open arrowheads). Views of the ventral surfaces of these same hearts are in Figure S3.
(I–L) Histological sections of control (I and J) and mutant (K and L) hearts at E13.5 immunostained with CD31 and endomucin (EMCN, venous marker). In the
control (J), superficial veins are EMCN-positive (arrows). In themutant (L), the open arrowhead in center points to an intramyocardial vessel ectopically expressing
endomucin, and the open arrowhead to the right points to a superficial dilated EMCN-negative vessel.
(M and N) Reduced number of major coronary artery branches (SM22+) in mutants (N) compared with controls (M) at E15.5.
(legend continued on next page)
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CXCL12/CXCR4 Signaling Is Required for Coronary
Vascular Maturation
We evaluated global Cxcl12/ embryos and Tie2Cre/Cxcr4
conditional mutant embryos to determine the role of CXCL12/
CXCR4 in coronary vasculogenesis. At E12.0, the number of
ventricular subepicardial endothelial cells, as visualized by
CD31 immunostaining (a pan-endothelial marker), was normal
in mutant embryos (Figures S3A and S3B), implying that
CXCL12 signaling is not required for chemotactic migration of
endothelial cells to the ventricle. Using whole-mount CD31
immunohistochemistry to visualize the forming vascular plexus,
we noted an expansion in mutant hearts compared with litter-
mate controls, on the dorsal ventricular surface at E11.5 and
on the ventral (anterior) surface at E12.5 (Figures 3A and 3E; Fig-
ures S3C, S3D, S3G, and S3K, quantitated in Figure S3E).
The expanded plexus in mutants included the peritruncal endo-
thelium (Figure S3K) from which the proximal coronary stems
are thought to originate (Tian et al., 2013a). Thus, just as addition
of CXCL12 does not promote initial vascular assembly in vitro
(Figure 1), absence of CXCL12 signaling does not impede initial
coronary plexus assembly in vivo. The expanded plexus in
mutant embryos is characteristic of a deficiency in maturation,
since plexus maturation includes pruning (elimination) of a
subset of capillary sprouts pursuant to remodeling into higher
order vessels. As the coronary plexus matures, arteries migrate
deeper into the myocardium, whereas veins remain close
to the ventricular surface. Using endomucin (Emcn) as a
venous marker, in mutant hearts we observed many examples
of CD31+Emcn vessels at the subepicardial ventricular surface,
and CD31+Emcn+ vessels in deeper intramyocardial arterial po-
sitions, whereas such mispositioned vessels were never seen in
control embryos (Figures 3J and 3L).Mispositioning is consistent
with persistence of vessels that should have been eliminated
from the earlier expanding plexus. Moreover, intramyocardial
vessels in mutants showed only weak expression of the arterial
marker NRP1 (Figures S3N–S3Q), and there were fewer intra-
myocardial arteries that displayed an SM22+ smooth muscle lin-
ing in mutants relative to controls (Figures 3M and 3N), both
implying compromised arterial differentiation. Thus, maturation
of the coronary plexus is compromised in the absence of
CXCL12-CXCR4 signaling, which is manifest by a transiently
expanded but ultimately unreorganized and poorly differentiated
vascular network.
Embryos with Deficient CXCL12 Signaling Have
Severely Compromised Coronary Arterial Vasculature
Whole-mount endomucin staining of mutant E15.5 hearts indi-
cated normal higher order organization of the venous compo-(O and P) Whole-mount EMCN staining at E15.5, indicating normal assembly of h
(Q–T) Visualization of the coronary arterial vasculature by aortic ink perfusion at E
organization in the mutant hearts (R and T) compared with controls (Q and S).
(U and V) Reduced number of major coronary artery branches in mutant hearts.
showing only SM22 (smooth muscle marker) staining. Close-up views of the boxe
Endothelial cell density is similar between control andmutant (compareU0 with V0).
dilated superficial vessels (open arrowheads) in the mutant.
(W and X) Close-up views of hearts from control (W, same as in Q) andCxcl12 KO
artery from the aorta into the adjacent persisting capillary plexus.
Abbreviations: Ao, aorta; endo, endocardium; lca, left coronary artery; rca, right
Devenent of the coronary vasculature (Figures 3O and 3P). Thus,
CXCL12 signaling is not required for venous coronary matura-
tion. We performed aortic ink perfusion to visualize the organiza-
tion of the coronary arterial vasculature in control and mutant
embryos in late gestation (Figures 3Q–3T; Figures S4A–S4C).
In normal hearts, the main proximal coronary branches give
rise to arteries of progressively smaller diameter that perfuse
the entire ventricle to the apex. In mutant hearts, in the vicinity
of the aorta we generally observed only a poorly differentiated
plexus that quickly terminated. When main proximal branches
were present, these also quickly terminated. The deficiency of
the peripheral arterial network in late-gestation mutant embryos
was not the result of absent vascular elements, because in
sections an abundance of small vessels was apparent in the ven-
tricular wall (Figures 3U and 3V). Many of these intramyocardial
vessels lacked a SM22+ smooth muscle lining and were there-
fore either mispositioned veins or immature vessels persisting
from the vascular plexus of earlier stages, although some
SM22+ arteries were also detected, consistent with the presence
of some arteries as visualized by ink perfusion. Importantly, at
least some proximal components of the coronary system were
perfused with ink in all mutant embryos (Figures 3R and 3T; Fig-
ures S4B and S4C), implying connection to the aorta, and coro-
nary ostia and proximal branches were readily observed in
mutant embryos (Figures 3W and 3X; Figures S4C–S4F).
CXCL12/CXCR4 signaling does not therefore appear to be
required for coronary ostia formation.
Perfusion of the coronary arteries initiates around E14 (Tian
et al., 2013a). The ventricular myocardium in mutants appeared
normal through E15 (Figures S3R–S3U), but in late-gestation
mutant embryos, we commonly observed ventricular hemor-
rhaging (Figures S4G and S4H), which we interpret as the result
of an immature, leaky vascular network following the onset of
coronary perfusion. As previously reported, Cxcl12 global and
Tie2Cre/Cxcr4 mutants appeared macroscopically normal
through E14.5; growth deficiency started at E15.5 and embryos
varied in time of lethality between E16.5 and E18.5. The compro-
mised coronary arterial network in mutant embryos is expected
to result in impaired heart growth and function after the E14
onset of coronary perfusion, which would result in diminished
embryo growth and ultimately in late-gestation embryo lethality.
Coronary Arterial Endothelial Cells Are Primarily
Derived from an Extracardiac Origin
The ventricular endocardium is the source of coronary endothe-
lium that forms after birth in the ventricular septum and inner ven-
tricular wall (Tian et al., 2014). However, there is uncertainty
regarding the cell lineage origin of embryonic coronaryigher order venous structures (arrowheads) in both mutant (P) and control (O).
15.5 and E16.5. Arrowheads point to perfused vessels of abnormal branching
(U) and (V) are low-magnification views of control and mutant hearts at E17.5
d regions are shown in U0, U00, V0, and V00 with CD31 and SM22 immunostaining.
Note smaller and fewer intramyocardial major branches (solid arrowheads) and
(X, shown in Figure S4C). In the mutant, note perfusion of the proximal coronary
coronary artery; sb, septal branch; co, coronary ostia. See also Figure S3.
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Figure 4. Coronary Endothelial Cells Are Derived from the Sinus Venosus
(A–C)Nfatc1Cre recombines in sinus venosus endothelial cell sprouts (three arrowheads at left) and in all endocardial cells at E11.5. (A)Nfatc1Cre recombination,
(B) CD31 positive endothelial cells, and (C) merged channels are shown.
(D and E) Nkx2.5Cre recombination at E11.5. (E) corresponds to the boxed area in (D). Nkx2.5Cre does not recombine in endothelial cells (CD31+) of the sinus
venosus and in endothelial cell sprouts of the sinus venosus moving toward the ventricle at the atrioventricular groove (open arrowheads).
(F)Nkx2.5Cre recombines efficiently in themyocardium, epicardium (arrows), and themajority of endocardial cells (solid arrowheads). A close-up confocal view of
a trabecular element is shown in separate (F0 and F00) and merged (F0 0 0) channels in the insets to emphasize that endocardial cells are labeled.
(G–I) Nkx2.5Cre recombination at E17.5. (G) shows a low-magnification view of the heart (green channel only). (H) and (I) correspond to the boxed areas in (G).
Nkx2.5Cre does not recombine in coronary artery or vein endothelium throughout the mature ventricle.
(legend continued on next page)
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endothelial cells, with the two principal sources argued to be
either the sinus venosus (Red-Horse et al., 2010; Tian et al.,
2013b) or the ventricular endocardium (Wu et al., 2012). Tie2Cre
is active in both and so does not address this issue; Nfatc1Cre,
which has been used in past studies to conclude an endocardial
origin of coronary arterial endothelium (Wu et al., 2012), is also
expressed in both (Figures 4A–4C).Nkx2.5Cre is active in the first
and second heart fields and therefore efficiently labels the atrial
and ventricular endocardium, myocardium, and epicardium, but
is not active in most vascular endothelium, including that of the
sinus venosus (Figures 4D–4F; Figures S4I–S4L). In normal
hearts, the great majority (>90%) of coronary endothelial cells
in the ventricular wall were unlabeled with the Nkx2.5Cre lineage
marker, whereas the great majority (>90%) of endocardial cells
and virtually all myocardial and epicardial cells were labeled.
The absence of labeling was clearly evident in large and small
caliber coronary arteries and in coronary veins (Figures 4G–4I;
FiguresS4KandS4L). The10%Nkx2.5Cre lineage-labeled cor-
onary endothelial cells implies a degree of heterogeneity in the
origin of this lineage, which was also noted in previous studies
(Red-Horse et al., 2010). Furthermore, unlike the invariable late-
gestation lethality of Tie2Cre/Cxcr4 mutants, Nkx2.5Cre/Cxcr4
mutants survived normally through adulthood with no apparent
deficiencies. Ink injection in late-gestation Nkx2.5Cre/Cxcr4
hearts demonstrated a normal coronary arterial pattern (Figures
4J and 4K), and the myocardium was also normal (Figures 4L
and 4M). These results suggest that the endothelial cell lineage
that responds to CXCL12 signaling through CXCR4 duringmatu-
ration of the coronary vasculature originates from outside the
Nkx2.5Credomain of the heart.Whilewecannot exclude thepos-
sibility that a subset of endocardium that does not express
Nkx2.5 selectively contributes to coronary endothelium, our ob-
servations support an origin from the sinus venosus.
DISCUSSION
Maturation of the vascular plexus is critically required for
adequate end-organ perfusion. Our studies show that CXCL12
is a necessary factor for coronary plexus maturation. Cxcl12
and Cxcr4 mutant embryos displayed a poorly formed coronary
arterial network that resulted in late-gestation underperfusion of
the heart, compromised heart growth and function, and embryo
lethality, all manifestations of a failure in plexus maturation. For
several reasons, we exclude a role for CXCL12 in earlier steps
of coronary development. A previous study showed that signals
from the ventricle are responsible for inducing migration of cor-
onary endothelial cells from the sinus venosus (Red-Horse
et al., 2010), but as we observed a normal density of endothelial
cells at all stages in normal versus mutant embryos, this signal is
not CXCL12. In Cxcl12 or Cxcr4 mutant embryos, initial plexus
formation was normal (and was even expanded because of the
lack of subsequent pruning), and in vitro, addition of CXCL12
did not influence VEGF-induced vascular sprouting. At the termi-(J and K) Normal coronary vasculature in E17.5 Nkx2.5Cre/Cxcr4 mutants and c
cavity.
(L and M) H&E staining of frontal sections showing normal heart morphology in b
Abbreviations: ra, right atria; sv, sinus venosus; rv, right ventricle; endo, endocard
right coronary artery; sb, septal branch. See also Figure S4.
Devenal phase of coronary vasculogenesis, ingrowth of anterior arte-
rial stems into the aorta results in the initiation of perfusion, and
this too occurred normally in mutant embryos with arterial ele-
ments that had properly matured in the vicinity of the aorta. We
thus conclude that CXCL12 acts in the ventricle as a vascular
plexus maturation factor needed for arterial differentiation (with
VEGF) and for hierarchical arterial assembly during coronary
development.
Interestingly, hierarchical organization of the coronary venous
system was normal in Cxcl12 and Cxcr4 mutants, implicating a
specific role for this signaling axis in arterial maturation. The ba-
sis for this selectivity is unclear, but suggests that coronary arte-
rial and venous maturation in the initial plexus involve distinct
molecular programs. This may be because the coronary endo-
thelium originates from a venous source (the sinus venosus),
such that coronary arterial endothelium must first be respecified
to an arterial fate. This may necessitate not only VEGF signaling
(to initiate arterialization) but also CXCL12 to promote further
maturation.
Several features distinguish the role of CXCL12 in coronary
vasculogenesis from previously described maturation factors
such as Notch, angiopoietin, and ephrin. First, unlike these gen-
eral factors, CXCL12 is clearly not required in all or even in most
vascular compartments. We examined coronary maturation in
mutant embryos, and previous studies have noted vascular de-
fects in the gut (Ara et al., 2005), kidney (Takabatake et al.,
2009), and skin (Li et al., 2013), but yolk sac and most embryonic
vessel beds were normal, and embryo growth, morphology, and
viability were normal until late gestation when coronary perfusion
becomes required. Second, CXCL12 is not absolutely required
for vessel maturation, since coronary artery formation was
evident although greatly limited in mutant embryos, and those
arteries that did form were able to assemble a smooth muscle
layer and become perfused with systemic blood. Importantly,
though, coronary vascular defects in Cxcl12/Cxcr4 mutants
were manifest prior to the initiation of perfusion, implying that
these defects are not the secondary consequence of impaired
flow. CXCL12 therefore appears to facilitate the process of
vascular maturation in select organ systems including the heart.
This probably occurs in conjunction with more general factors; in
this light, Notch signaling has been reported to controlCxcr4 and
Cxcl12 expression in myeloma and mesenchymal cells (Miran-
dola et al., 2013; Xie et al., 2013). This role of facilitating vascular
maturation may also explain the phenotype observed in the
developing gut (Ara et al., 2005) and possibly also in kidney (Ta-
kabatake et al., 2009). Finally, unlike Notch, angiopoietin, and
ephrin signaling in which both ligand and receptor are expressed
by endothelial cells and control vessel maturation largely by au-
tocrine interactions, CXCL12 functions as a paracrine factor
that influences adjacent CXCR4-expressing endothelial cells.
In coronary development, CXCL12 is expressed by the epicar-
dium and epicardium-derived mesenchymal cells and to a
lesser extent by the myocardium (Figure 2), and in the kidneyontrol (J); the asterisk in (K) indicates leaking of excess ink into the ventricular
oth control (L) and mutant (M) hearts at E17.5.
ium; li, liver; ca, coronary artery; cv, coronary vein; lca, left coronary artery; rca,
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CXCL12 is expressed by podocytes (Takabatake et al., 2009).
The requirement for a nearby source of CXCL12 might explain
why only some organ systems utilize it for vascular maturation.
Our prior results demonstrated that the epicardium expresses
IGF2, which is required for cardiomyocyte proliferation and
expansion of the ventricular wall (Li et al., 2011; Shen et al.,
2015). IGF2 has no apparent role in coronary formation or matu-
ration, and in the present study, CXCL12 signaling had no
apparent role in the myocardium. These two epicardial factors
therefore independently regulate different aspects of heart
development. The expansion of the ventricular wall in response
to IGF2 initiates from E10 (the time of formation of the epicar-
dium) when growth substrates such as oxygen and glucose
can diffuse into the myocardium from the ventricular lumen. As
this process progresses, diffusion across the thickening ventric-
ular wall becomes increasingly more limiting. CXCL12 during the
E11.5–E14.5 period promotes the assembly of the coronary
vasculature, so that the onset of coronary perfusion around
E14 provides a new means of distributing materials to the
myocardium and thereby supporting heart and embryonic
growth to the end of gestation.
EXPERIMENTAL PROCEDURES
Fibrin Bead Assay
Dextran-coated Cytodex 3 microcarriers were coated with HUVECs, resus-
pended in fibrinogen, and added towells of a 24-well plate containing thrombin
to allow clotting. 1 ml of endothelial basal media containing 2% fetal bovine
serum (FBS) with or without VEGF, CXCL12, or AMD3100 was added to
each well, and dermal fibroblasts were plated on top of the clot. Beads were
photographed at 53 magnification after 3–7 days in culture; sprout number,
tube number, branching points, and anastomoses were manually quantified
from multiple microscopic fields per well.
Mice
All mice were housed and bred within the animal facility at the University of
Southern California in accordance with Institutional Animal Care and Use
Committee guidance. All mouse lines used in this study have been described
previously, as follows: Cxcl12 mutant (Ara et al., 2003), conditional Cxcr4 (Nie
et al., 2004), Tie2Cre transgenic (Kisanuki et al., 2001), Nfatc1Cre (Zhou et al.,
2002), Nkx2.5Cre knockin (Moses et al., 2001), and conditional R26lacZ and
R26YFP (Soriano, 1999).
India Ink Coronary Artery Perfusion
Hearts were carefully dissected from the thoracic regions of E15.5–E17.5 em-
bryos and transferred to DMEM/10%FBS/heparin on ice. India ink diluted in
PSB/heparin was then injected via the ascending aorta by mouth pipetting
with a borosilicate glass tube. Hearts were fixed, dehydrated, cleared in benzyl
alcohol:benzyl benzoate (1:1), and imaged with a stereomicroscope.
Additional and detailed experimental procedures are described in the Sup-
plemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2015.03.018.
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